In the breast cancer datasets, this factor is associated with ICT resistance (Fig. 5c), and studies of its marker genes suggest that they are involved in suppressing antitumor immunity (FABP5 (ref. 75) and TREM1 (ref. 63)). The gene discussed is FABP5; the disease is breast cancer.